Allergan has introduced a new dermal filler, said to hydrate the skin while plumping it. Juvéderm Hydrate, which is made of Hyaluronic acid (HA), works like other fillers that are currently on the market with the added benefit of skin hydrating properties.
Findings presented at the 8th Anti-Aging Medicine World Congress in Monte Carlo, Monaco, show that Juvéderm Hydrate could set new standards for skin rejuvenation therapy. The active ingredient in Juvéderm Hydrate, Hyaluronic acid, is common used in dermal fillers due to its watery consistency and sponge-like effect upon injection. The loss of this naturally occurring compound in skin increases the appearance of fine lines, wrinkles and folds.
The study of Juvéderm Hydrate was conducted on 27 women in France. The patients who had a mean age of 42.6 years were injected in areas including their neckline, perioral, cheeks and eyes. Researchers then assessed the patients’ skin 15, 30 and 60 days following injection. According to the study, both patient and doctor satisfaction analysis reports showed that 90% of the participants had ‘improved’ skin after day 60. Not only that, 80% of patients saw ‘very improved’ skin with Juvéderm Hydrate after day 60.
Eighty-five percent of the treated subjects said they would recommend Juvéderm Hydrate to their friend(s) as well as undergo future treatments. Because of their lower costs and shorter downtime, non-invasive skin treatments are extremely popular. Juvéderm Hydrate is not currently FDA approved for use in the American market, however, it is available in Germany, France, Spain, Italy and England.